PD-L1 stimulation can promote proliferation and survival of leukemic cells by influencing glucose and fatty acid metabolism in acute myeloid leukemia
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- Extent
-
Online-Ressource, 1 online resource.
- Language
-
Englisch
- Bibliographic citation
-
PD-L1 stimulation can promote proliferation and survival of leukemic cells by influencing glucose and fatty acid metabolism in acute myeloid leukemia ; volume:23 ; number:1 ; day:16 ; month:5 ; year:2023 ; pages:1-9 ; date:12.2023
BMC cancer ; 23, Heft 1 (16.5.2023), 1-9, 12.2023
- Creator
-
Soltani, Mojdeh
Ghanadian, Mustafa
Ghezelbash, Behrooz
Shokouhi, Abolfazl
Zamyatnin, Andrey A.
Bazhin, Alexandr V.
Ganjalikhani-Hakemi, Mazdak
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1186/s12885-023-10947-7
- URN
-
urn:nbn:de:101:1-2023090812563771626436
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
14.08.2025, 10:50 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Soltani, Mojdeh
- Ghanadian, Mustafa
- Ghezelbash, Behrooz
- Shokouhi, Abolfazl
- Zamyatnin, Andrey A.
- Bazhin, Alexandr V.
- Ganjalikhani-Hakemi, Mazdak
- SpringerLink (Online service)
Other Objects (12)
Anti-TIGIT antibody improves PD-L1 blockade through myeloid and Treg cells
Targeting PD-1/PD-L1 pathway in myelodysplastic syndromes and acute myeloid leukemia
Utility of PD-L1 immunohistochemistry assays for predicting PD-1/PD-L1 inhibitor response
Platelet PD-L1 suppresses anti-cancer immune cell activity in PD-L1 negative tumors
Publisher Correction: Anti-TIGIT antibody improves PD-L1 blockade through myeloid and Treg cells
Author Correction: Anti-TIGIT antibody improves PD-L1 blockade through myeloid and Treg cells
STAT5 promotes PD-L1 expression by facilitating histone lactylation to drive immunosuppression in acute myeloid leukemia
PD-L1 Expression als Prognosemarker beim Endometriumkarzinom
Factors correlating the expression of PD-L1
Optimized PD-L1 scoring of gastric cancer
Prognostic value of soluble PD-L1 and exosomal PD-L1 in advanced gastric cancer patients receiving systemic chemotherapy
Improvement of the anticancer efficacy of PD-1/PD-L1 blockade via combination therapy and PD-L1 regulation
Anti-TIGIT antibody improves PD-L1 blockade through myeloid and Treg cells
Targeting PD-1/PD-L1 pathway in myelodysplastic syndromes and acute myeloid leukemia
Utility of PD-L1 immunohistochemistry assays for predicting PD-1/PD-L1 inhibitor response
Platelet PD-L1 suppresses anti-cancer immune cell activity in PD-L1 negative tumors
Publisher Correction: Anti-TIGIT antibody improves PD-L1 blockade through myeloid and Treg cells
Author Correction: Anti-TIGIT antibody improves PD-L1 blockade through myeloid and Treg cells
STAT5 promotes PD-L1 expression by facilitating histone lactylation to drive immunosuppression in acute myeloid leukemia
PD-L1 Expression als Prognosemarker beim Endometriumkarzinom
Factors correlating the expression of PD-L1
Optimized PD-L1 scoring of gastric cancer
Prognostic value of soluble PD-L1 and exosomal PD-L1 in advanced gastric cancer patients receiving systemic chemotherapy
Improvement of the anticancer efficacy of PD-1/PD-L1 blockade via combination therapy and PD-L1 regulation
Anti-TIGIT antibody improves PD-L1 blockade through myeloid and Treg cells
Targeting PD-1/PD-L1 pathway in myelodysplastic syndromes and acute myeloid leukemia
Utility of PD-L1 immunohistochemistry assays for predicting PD-1/PD-L1 inhibitor response
Platelet PD-L1 suppresses anti-cancer immune cell activity in PD-L1 negative tumors
Publisher Correction: Anti-TIGIT antibody improves PD-L1 blockade through myeloid and Treg cells
Author Correction: Anti-TIGIT antibody improves PD-L1 blockade through myeloid and Treg cells
STAT5 promotes PD-L1 expression by facilitating histone lactylation to drive immunosuppression in acute myeloid leukemia
PD-L1 Expression als Prognosemarker beim Endometriumkarzinom
Factors correlating the expression of PD-L1
Optimized PD-L1 scoring of gastric cancer
Prognostic value of soluble PD-L1 and exosomal PD-L1 in advanced gastric cancer patients receiving systemic chemotherapy